Myla Maloney, Chief Growth Officer at Premier Applied Sciences, discusses how data, artificial intelligence and digital innovation are transforming healthcare. By integrating both clinical and supply chain data, Premier leverages real-world evidence for regulatory submissions, reducing the need for traditional clinical trials. Premier also uses tokenization to enhance data integration, including pharmacy and genomics data, offering comprehensive insights to reduce trial time.

By leveraging Premier's unique data set, which spans over 320 million patients and includes both clinical and supply chain data, the webinar demonstrates how this comprehensive resource is being utilized to drive better decision-making in healthcare. Maloney discusses how Premier’s data meets the U.S. Food and Drug Administration’s (FDA’s) standards for real-world evidence and highlights its impact across various industries, including life sciences, pharmaceutical, and medical device sectors.

• Premier’s Network and Data Assets: Premier collaborates with over 4,350 hospitals and health systems, leveraging its Premier Healthcare Database (PHD), which includes over 320 million unique patient records and 100 million annual supply chain transactions, providing deep insights into patient demographics, encounters and outcomes.

• Comprehensive Data Integration and Insights: Through tokenization, Premier can incorporate external data, offering a HIPAA-compliant, multifaceted view of patient health to support real-world evidence submissions approvals.

• Trusted Partner for Healthcare Innovation: Premier’s data is trusted by life sciences companies, government agencies and the FDA, positioning the company as a leader in healthcare analytics and research, with unique strengths in clinical data, supply chain insights and healthcare system relationships.

Myla Maloney, MBA, BCMAS
Chief Growth Officer, Premier Applied Sciences